Vault-13

SECTORAL ASSET MANAGEMENT INC

MONTREAL, A8 · CIK 1274413 · 13F filing filed 2026-08-14

SEC-registered investment adviser since 2001 · corporation

As an employer

$143.3m reported value +18.7% vs Q1 2026
82positions
39.6%in top 10
15 new 17 added 17 reduced 10 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CONTINEUM THERAPEUTICS INC CL A CTNM CTNM 727,587 $11.9m8.32% 8.32% UnchangedShares held: Q3 2025 800.8k, Q4 2025 800.8k, Q1 2026 727.6k, Q2 2026 727.6k
2 SHOULDER INNOVATIONS INC COMMON STOCK SI SI 430,407 $8.7m6.09% 6.09% UnchangedShares held: Q3 2025 430.3k, Q4 2025 492.4k, Q1 2026 430.4k, Q2 2026 430.4k
3 ELI LILLY & CO COM LLY LLY 6,354 $7.6m5.32% 5.32% UnchangedShares held: Q3 2025 9.4k, Q4 2025 7.3k, Q1 2026 6.4k, Q2 2026 6.4k
4 UNITEDHEALTH GROUP INC COM UNH UNH 13,235 $5.5m3.84% 3.84% ReducedShares held: Q3 2025 13.5k, Q4 2025 13.6k, Q1 2026 15.0k, Q2 2026 13.2k -1.7k -1,722 -11.5%
5 JOHNSON & JOHNSON COM JNJ JNJ 18,218 $4.6m3.23% 3.23% UnchangedShares held: Q3 2025 15.3k, Q4 2025 20.3k, Q1 2026 18.2k, Q2 2026 18.2k
6 ORUKA THERAPEUTICS INC COM ORKA ORKA 41,987 $4.0m2.79% 2.79% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 42.0k
7 BIONTECH SE SPONSORED ADS BNTX BNTX 41,869 $3.9m2.72% 2.72% AddedShares held: Q3 2025 17.7k, Q4 2025 17.2k, Q1 2026 22.2k, Q2 2026 41.9k +19.7k +19,705 88.9%
8 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 78,310 $3.7m2.57% 2.57% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 78.3k
9 DEXCOM INC COM DXCM DXCM 50,756 $3.4m2.39% 2.39% AddedShares held: Q3 2025 20.7k, Q4 2025 28.7k, Q1 2026 23.2k, Q2 2026 50.8k +27.5k +27,525 118.5%
10 ARCUS BIOSCIENCES INC COM RCUS RCUS 110,870 $3.4m2.39% 2.39% AddedShares held: Q3 2025 368.1k, Q4 2025 56.9k, Q1 2026 45.1k, Q2 2026 110.9k +65.8k +65,800 146.0%
11 AMGEN INC COM AMGN AMGN 9,210 $3.3m2.33% 2.33% UnchangedShares held: Q3 2025 10.3k, Q4 2025 13.1k, Q1 2026 9.2k, Q2 2026 9.2k
12 SUMMIT THERAPEUTICS INC COM SMMT SMMT 220,180 $3.2m2.24% 2.24% AddedShares held: Q3 2025 74.1k, Q4 2025 79.6k, Q1 2026 69.6k, Q2 2026 220.2k +150.6k +150,565 216.3%
13 IRHYTHM TECHNOLOGIES INC COM IRTC IRTC 26,070 $3.1m2.16% 2.16% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 26.1k
14 ABBVIE INC COM ABBV ABBV 12,200 $3.1m2.14% 2.14% UnchangedShares held: Q3 2025 14.8k, Q4 2025 16.8k, Q1 2026 12.2k, Q2 2026 12.2k
15 MERCK & CO INC COM MRK MRK 21,480 $2.8m1.94% 1.94% UnchangedShares held: Q3 2025 16.4k, Q4 2025 21.4k, Q1 2026 21.5k, Q2 2026 21.5k
16 ARRIVENT BIOPHARMA INC COM AVBP AVBP 79,043 $2.7m1.92% 1.92% AddedShares held: Q3 2025 39.2k, Q4 2025 38.3k, Q1 2026 30.0k, Q2 2026 79.0k +49.0k +49,030 163.4%
17 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 5,432 $2.7m1.88% 1.88% ReducedShares held: Q3 2025 7.7k, Q4 2025 8.0k, Q1 2026 7.0k, Q2 2026 5.4k -1.6k -1,575 -22.5%
18 ARGENX SE SPONSORED ADR ARGX ARGX 2,831 $2.6m1.83% 1.83% ReducedShares held: Q3 2025 3.9k, Q4 2025 2.9k, Q1 2026 3.6k, Q2 2026 2.8k -733 -733 -20.6%
19 GILEAD SCIENCES INC COM GILD GILD 20,620 $2.6m1.82% 1.82% ReducedShares held: Q3 2025 19.6k, Q4 2025 17.9k, Q1 2026 27.5k, Q2 2026 20.6k -6.9k -6,870 -25.0%
20 INSMED INC COM PAR $.01 INSM INSM 23,216 $2.5m1.73% 1.73% AddedShares held: Q3 2025 13.4k, Q4 2025 11.2k, Q1 2026 19.7k, Q2 2026 23.2k +3.5k +3,548 18.0%
21 TECTONIC THERAPEUTIC INC COM TECX TECX 71,009 $2.4m1.70% 1.70% AddedShares held: Q3 2025 192.8k, Q4 2025 42.3k, Q1 2026 19.1k, Q2 2026 71.0k +52.0k +51,950 272.6%
22 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 5,850 $2.3m1.62% 1.62% AddedShares held: Q3 2025 5.8k, Q4 2025 4.8k, Q1 2026 5.2k, Q2 2026 5.8k +600 +600 11.4%
23 IMMATICS N.V SHS IMTX IMTX 224,928 $2.3m1.59% 1.59% AddedShares held: Q3 2025 560.5k, Q4 2025 63.0k, Q1 2026 66.8k, Q2 2026 224.9k +158.1k +158,098 236.6%
24 STRYKER CORPORATION COM SYK SYK 7,129 $2.2m1.57% 1.57% AddedShares held: Q3 2025 4.3k, Q4 2025 6.5k, Q1 2026 5.9k, Q2 2026 7.1k +1.3k +1,255 21.4%
25 AVALO THERAPEUTICS INC COM NEW AVTX AVTX 119,923 $2.2m1.55% 1.55% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 119.9k
26 CRESCENT BIOPHARMA INC. COM CBIO CBIO 121,300 $2.2m1.52% 1.52% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 121.3k
27 ROIVANT SCIENCES LTD SHS ROIV ROIV 61,100 $2.2m1.51% 1.51% AddedShares held: Q3 2025 50.0k, Q4 2025 45.3k, Q1 2026 32.5k, Q2 2026 61.1k +28.6k +28,600 88.0%
28 IQVIA HLDGS INC COM IQV IQV 10,848 $2.1m1.46% 1.46% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 8.3k, Q2 2026 10.8k +2.5k +2,541 30.6%
29 PULSE BIOSCIENCES INC COM PLSE PLSE 67,895 $1.9m1.31% 1.31% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 67.9k
30 DANAHER CORPORATION COM DHR DHR 9,597 $1.8m1.28% 1.28% UnchangedShares held: Q3 2025 10.6k, Q4 2025 10.6k, Q1 2026 9.6k, Q2 2026 9.6k
31 THERMO FISHER SCIENTIFIC INC COM TMO TMO 3,508 $1.8m1.23% 1.23% UnchangedShares held: Q3 2025 3.9k, Q4 2025 3.9k, Q1 2026 3.5k, Q2 2026 3.5k
32 ABBOTT LABS COM ABT ABT 18,080 $1.6m1.14% 1.14% ReducedShares held: Q3 2025 17.2k, Q4 2025 23.5k, Q1 2026 25.6k, Q2 2026 18.1k -7.5k -7,498 -29.3%
33 ALPHATEC HLDGS INC COM NEW ATEC ATEC 185,900 $1.6m1.12% 1.12% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 185.9k
34 BOSTON SCIENTIFIC CORP COM BSX BSX 36,330 $1.6m1.08% 1.08% AddedShares held: Q3 2025 22.1k, Q4 2025 27.6k, Q1 2026 34.8k, Q2 2026 36.3k +1.6k +1,550 4.5%
35 TRANSMEDICS GROUP INC COM TMDX TMDX 21,950 $1.5m1.02% 1.02% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 21.9k
36 CYTOKINETICS INC COM NEW CYTK CYTK 16,330 $1.4m0.97% 0.97% AddedShares held: Q3 2025 10.2k, Q4 2025 5.9k, Q1 2026 7.3k, Q2 2026 16.3k +9.0k +9,030 123.7%
37 REGENERON PHARMACEUTICALS COM REGN REGN 2,169 $1.4m0.94% 0.94% ReducedShares held: Q3 2025 4.0k, Q4 2025 3.7k, Q1 2026 2.9k, Q2 2026 2.2k -750 -750 -25.7%
38 CVS HEALTH CORP COM CVS CVS 13,000 $1.3m0.94% 0.94% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 13.0k
39 EDWARDS LIFESCIENCES CORP COM EW EW 14,826 $1.3m0.94% 0.94% ReducedShares held: Q3 2025 15.0k, Q4 2025 17.2k, Q1 2026 17.3k, Q2 2026 14.8k -2.5k -2,512 -14.5%
40 TREVI THERAPEUTICS INC COM TRVI TRVI 65,596 $1.2m0.85% 0.85% ReducedShares held: Q3 2025 106.0k, Q4 2025 84.3k, Q1 2026 74.4k, Q2 2026 65.6k -8.8k -8,850 -11.9%
41 BRISTOL-MYERS SQUIBB CO COM BMY BMY 21,150 $1.2m0.85% 0.85% UnchangedShares held: Q3 2025 10.8k, Q4 2025 0, Q1 2026 21.1k, Q2 2026 21.1k
42 VERA THERAPEUTICS INC CL A VERA VERA 25,573 $1.1m0.77% 0.77% UnchangedShares held: Q3 2025 30.2k, Q4 2025 36.9k, Q1 2026 25.6k, Q2 2026 25.6k
43 COGENT BIOSCIENCES INC COM COGT COGT 26,740 $1.0m0.72% 0.72% AddedShares held: Q3 2025 0, Q4 2025 32.7k, Q1 2026 22.1k, Q2 2026 26.7k +4.6k +4,600 20.8%
44 MEDTRONIC PLC SHS MDT MDT 11,100 $876.3k0.61% 0.61% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 11.1k, Q2 2026 11.1k
45 TARSUS PHARMACEUTICALS INC COM TARS TARS 13,285 $836.2k0.58% 0.58% AddedShares held: Q3 2025 18.4k, Q4 2025 14.7k, Q1 2026 11.3k, Q2 2026 13.3k +2.0k +2,013 17.9%
46 KURA ONCOLOGY INC COM KURA KURA 71,480 $784.1k0.55% 0.55% UnchangedShares held: Q3 2025 395.9k, Q4 2025 54.1k, Q1 2026 71.5k, Q2 2026 71.5k
47 CENTENE CORP DEL COM CNC CNC 12,000 $770.3k0.54% 0.54% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 12.0k
48 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 1,370 $742.3k0.52% 0.52% ReducedShares held: Q3 2025 765, Q4 2025 1.7k, Q1 2026 1.7k, Q2 2026 1.4k -340 -340 -19.9%
49 HINGE HEALTH INC CL A HNGE HNGE 8,744 $725.8k0.51% 0.51% ReducedShares held: Q3 2025 11.2k, Q4 2025 14.2k, Q1 2026 12.2k, Q2 2026 8.7k -3.5k -3,500 -28.6%
50 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 10,111 $705.8k0.49% 0.49% ReducedShares held: Q3 2025 0, Q4 2025 13.5k, Q1 2026 10.9k, Q2 2026 10.1k -740 -740 -6.8%
51 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 2,310 $695.4k0.49% 0.49% UnchangedShares held: Q3 2025 3.3k, Q4 2025 3.0k, Q1 2026 2.3k, Q2 2026 2.3k
52 ASCENDIS PHARMA A/S ORD SHS ASND ASND 2,570 $685.5k0.48% 0.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.6k
53 PFIZER INC COM PFE PFE 27,500 $662.2k0.46% 0.46% UnchangedShares held: Q3 2025 77.2k, Q4 2025 27.1k, Q1 2026 27.5k, Q2 2026 27.5k
54 ARDELYX INC COM ARDX ARDX 122,394 $624.2k0.44% 0.44% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 122.4k, Q2 2026 122.4k
55 PRIVIA HEALTH GROUP INC COM PRVA PRVA 24,136 $621.0k0.43% 0.43% ReducedShares held: Q3 2025 36.5k, Q4 2025 26.0k, Q1 2026 27.1k, Q2 2026 24.1k -3.0k -3,000 -11.1%
56 PTC THERAPEUTICS INC COM PTCT PTCT 7,470 $609.3k0.43% 0.43% AddedShares held: Q3 2025 8.5k, Q4 2025 7.7k, Q1 2026 6.7k, Q2 2026 7.5k +820 +820 12.3%
57 IONIS PHARMACEUTICALS INC COM IONS IONS 7,200 $570.9k0.40% 0.40% UnchangedShares held: Q3 2025 9.2k, Q4 2025 8.4k, Q1 2026 7.2k, Q2 2026 7.2k
58 AGOMAB THERAPEUTICS NV SPONSORED ADS AGMB AGMB 43,500 $564.6k0.39% 0.39% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 43.5k, Q2 2026 43.5k
59 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 9,450 $540.7k0.38% 0.38% UnchangedShares held: Q3 2025 25.0k, Q4 2025 10.9k, Q1 2026 9.4k, Q2 2026 9.4k
60 BEIGENE LTD SPONSORED ADR ONC ONC 1,870 $532.9k0.37% 0.37% UnchangedShares held: Q3 2025 7.2k, Q4 2025 2.7k, Q1 2026 1.9k, Q2 2026 1.9k
61 HUMANA INC COM HUM HUM 1,250 $497.3k0.35% 0.35% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 1.2k
62 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 1,750 $421.7k0.29% 0.29% UnchangedShares held: Q3 2025 2.2k, Q4 2025 2.0k, Q1 2026 1.8k, Q2 2026 1.8k
63 ROYALTY PHARMA PLC SHS CLASS A RPRX RPRX 7,200 $403.7k0.28% 0.28% UnchangedShares held: Q3 2025 9.3k, Q4 2025 8.5k, Q1 2026 7.2k, Q2 2026 7.2k
64 BIOGEN INC COM BIIB BIIB 1,850 $399.7k0.28% 0.28% UnchangedShares held: Q3 2025 2.4k, Q4 2025 2.2k, Q1 2026 1.9k, Q2 2026 1.9k
65 MINERALYS THERAPEUTICS INC COM MLYS MLYS 14,565 $393.0k0.27% 0.27% ReducedShares held: Q3 2025 33.9k, Q4 2025 31.6k, Q1 2026 31.6k, Q2 2026 14.6k -17.1k -17,053 -53.9%
66 ILLUMINA INC COM ILMN ILMN 2,132 $374.9k0.26% 0.26% UnchangedShares held: Q3 2025 2.7k, Q4 2025 2.5k, Q1 2026 2.1k, Q2 2026 2.1k
67 AXSOME THERAPEUTICS INC COM AXSM AXSM 1,500 $367.2k0.26% 0.26% UnchangedShares held: Q3 2025 1.0k, Q4 2025 1.7k, Q1 2026 1.5k, Q2 2026 1.5k
68 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 15,680 $342.8k0.24% 0.24% ReducedShares held: Q3 2025 79.4k, Q4 2025 61.2k, Q1 2026 31.7k, Q2 2026 15.7k -16.0k -16,000 -50.5%
69 REVOLUTION MEDICINES INC COM RVMD RVMD 1,830 $342.7k0.24% 0.24% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 1.8k, Q2 2026 1.8k
70 ABIVAX SA SPONSORED ADS ABVX ABVX 2,340 $311.8k0.22% 0.22% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.3k, Q2 2026 2.3k
71 BRIDGEBIO PHARMA INC COM BBIO BBIO 4,100 $305.4k0.21% 0.21% ReducedShares held: Q3 2025 13.7k, Q4 2025 11.2k, Q1 2026 8.1k, Q2 2026 4.1k -4.0k -4,000 -49.4%
72 MODERNA INC COM MRNA MRNA 4,350 $304.6k0.21% 0.21% UnchangedShares held: Q3 2025 5.6k, Q4 2025 5.0k, Q1 2026 4.3k, Q2 2026 4.3k
73 GUARDANT HEALTH INC COM GH GH 1,980 $297.1k0.21% 0.21% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.0k, Q2 2026 2.0k
74 INCYTE CORP COM INCY INCY 2,350 $266.4k0.19% 0.19% UnchangedShares held: Q3 2025 3.0k, Q4 2025 2.8k, Q1 2026 2.4k, Q2 2026 2.4k
75 ORIC PHARMACEUTICALS INC COM ORIC ORIC 23,500 $254.5k0.18% 0.18% UnchangedShares held: Q3 2025 328.7k, Q4 2025 22.5k, Q1 2026 23.5k, Q2 2026 23.5k
76 ARS PHARMACEUTICALS INC COM SPRY SPRY 29,900 $239.5k0.17% 0.17% ReducedShares held: Q3 2025 81.8k, Q4 2025 29.8k, Q1 2026 79.2k, Q2 2026 29.9k -49.2k -49,250 -62.2%
77 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 4,325 $232.1k0.16% 0.16% ReducedShares held: Q3 2025 221.9k, Q4 2025 23.9k, Q1 2026 14.1k, Q2 2026 4.3k -9.8k -9,777 -69.3%
78 MEDPACE HLDGS INC COM MEDP MEDP 430 $227.7k0.16% 0.16% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 430, Q2 2026 430
79 TEMPUS AI INC CL A TEM TEM 3,880 $224.8k0.16% 0.16% NewShares held: Q3 2025 3.8k, Q4 2025 4.5k, Q1 2026 0, Q2 2026 3.9k
80 CORBUS PHARMACEUTICALS HLDGS COM NEW CRBP CRBP 20,000 $187.6k0.13% 0.13% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 20.0k
81 PALISADE BIO INC COM PALI PALI 88,000 $183.9k0.13% 0.13% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 88.0k, Q2 2026 88.0k
82 ENGENE THERAPEUTICS INC COM ENGN ENGN 21,700 $37.5k0.03% 0.03% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 21.7k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
EVOMMUNE INC EVMN EVMN 589,005 $13.5m589.0k shares
RAPPORT THERAPEUTICS INC RAPP RAPP 25,421 $835.0k25.4k shares
BOUNDLESS BIO INC BOLD BOLD 678,574 $746.4k678.6k shares
ASCENDIS PHARMA A/S 2,800 $728.3k2.8k shares
UNIQURE NV QURE QURE 29,245 $499.4k29.2k shares
ALIGNMENT HEALTHCARE INC ALHC ALHC 26,911 $474.2k26.9k shares
RADNET INC RDNT RDNT 7,999 $447.1k8.0k shares
INSPIRE MED SYS INC INSP INSP 7,225 $372.7k7.2k shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 2,300 $343.8k2.3k shares
OMADA HEALTH INC OMDA OMDA 25,620 $322.0k25.6k shares